Skip to content
Screener

Orthofix Medical Inc. OFIX Net Change in Cash

Net Change in Cash at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.98B-86.2%
Stryker logo
StrykerSYK
$513M
Globus Medical logo
Globus MedicalGMED
-$53.21M+77.0%
Alphatec Holdings logo
Alphatec HoldingsATEC
-$20.89M-245%
Enovis logo
EnovisENOV
-$20.57M
OrthoPediatrics logo
OrthoPediatricsKIDS
-$7.38M+28.7%

Other financials

Income statement

See full
Revenue$210.9M+3.8%
Gross profit$149.7M+7.3%
Operating income-$8.1M+49.2%
Net income-$15.8M-12.2%
EPS (diluted)-$0.39-8.3%

Balance sheet

See full
Cash & equivalents$103.8M+58.2%
Total debt$237.7M+33.3%
Total equity$429.2M-6.4%
Total assets$873.0M+4.3%

Cash flow

See full
Operating cash flow-$6.2M-153%
CapEx$12.6M+77.9%
Free cash flow-$18.9M

Valuation

See full
Market cap$418.73M-18.1%
Enterprise value$552.6M-11.4%
P/S0.5×-0.1×

Profitability

See full
Gross margin71.3%+3.9pp
Operating margin-4.8%-1.8pp
Net margin-7.4%-2.5pp
FCF margin-9.7%-1.8pp

Returns & leverage

See full
Return on equity-13.9%-4.2pp
Debt / equity0.6×+0.2×
Current ratio2.8×+0.2×

Where this comes from

Reported directly by Orthofix Medical Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The source filing: Orthofix Medical Inc.’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 7:03 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-205003
(Unaudited, U.S. Dollars, in thousands)Three Months Ended March 31, 2026Three Months Ended March 31, 2025
Payment of debt issuance costs and other financing activities(24)(512)
Net cash provided by (used in) financing activities63,970(651)
Effect of exchange rate changes on cash(90)493
Net change in cash and cash equivalents35,755(25,285)
Cash, cash equivalents, and restricted cash at the beginning of period85,11585,738
Cash, cash equivalents, and restricted cash at the end of period$120,870$60,453
Components of cash, cash equivalents, and restricted cash at the end of period
Cash and cash equivalents$120,278$57,953

Item 1. Financial Statements

FAQ

What is Orthofix Medical Inc.'s net change in cash?
Orthofix Medical Inc. (OFIX) reported net change in cash of $35.76M in Q1 2026.
How has Orthofix Medical Inc.'s net change in cash changed year-over-year?
Orthofix Medical Inc.'s net change in cash increased by 241.4% year-over-year, from -$25.29M to $35.76M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Ask your AI about Orthofix Medical Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude